Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| METFORMIN ER | SANIS HEALTH INC | Marketed | Jan 8, 2026 | Marketed |
| OCTREOTIDE INJECTION | Sterimax Inc | Marketed | Jan 7, 2026 | Marketed |
| ARGATROBAN FOR INJECTION | JUNO PHARMA CANADA INC. | Marketed | Jan 7, 2026 | Marketed |
| ILUMYA | SUN PHARMACEUTICAL INDUSTRIES LIMITED | Marketed | Jan 6, 2026 | Marketed |
| OCTREOTIDE INJECTION | Sterimax Inc | Marketed | Jan 5, 2026 | Marketed |
| OCTREOTIDE INJECTION | Sterimax Inc | Marketed | Jan 5, 2026 | Marketed |
| AGE CONTROL SUPREME SUBLIME ADVANCED CRÈME DE JOUR FPS 30 DAY CREAM SPF 30 | GROUPE MARCELLE INC | Marketed | Jan 5, 2026 | Marketed |
| AURO-CANAGLIFLOZIN | AURO PHARMA INC | Marketed | Jan 2, 2026 | Marketed |
| ULTRA HYDRATING SUNSCREEN | PENTA KARE LABS, INC. | Marketed | Jan 2, 2026 | Marketed |
| JAMP CANAGLIFLOZIN | Jamp Pharma Corporation | Marketed | Jan 2, 2026 | Marketed |
| AURO-CANAGLIFLOZIN | AURO PHARMA INC | Marketed | Jan 2, 2026 | Marketed |
| JAMP CANAGLIFLOZIN | Jamp Pharma Corporation | Marketed | Jan 2, 2026 | Marketed |
| METFORMIN ER | SANIS HEALTH INC | Marketed | Dec 29, 2025 | Marketed |
| APO-CLADRIBINE | Apotex Inc | Marketed | Dec 22, 2025 | Marketed |
| JAMP NINTEDANIB | Jamp Pharma Corporation | Marketed | Dec 22, 2025 | Marketed |
| ISTURISA | RECORDATI RARE DISEASES CANADA INC | Marketed | Dec 17, 2025 | Marketed |
| ISTURISA | RECORDATI RARE DISEASES CANADA INC | Marketed | Dec 17, 2025 | Marketed |
| LEQEMBI | EISAI LIMITED | Marketed | Dec 16, 2025 | Marketed |
| MULTI-DEFENSE REPLENISHING CREAM SPF 45 | GROUPE MARCELLE INC | Marketed | Dec 9, 2025 | Marketed |
| MULTI-DEFENSE REPLENISHING LOTION SPF 45 | GROUPE MARCELLE INC | Marketed | Dec 8, 2025 | Marketed |
